HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
1326studies shown
Showing 1,213-1,224 of 1,326
Other study type icon
CompletedNCT03954522

The Visiting Child and His Family in ICU

Official study title

Evaluation in Children of the Psychological Impact of the Visit of a Hospitalized Relative in ICU

This study has finished and is no longer accepting participants.

In France
PTSDInterventional studyAges 6+
Countries
France
Sponsor
Centre Hospitalier Universitaire de Besancon
Other study type icon
CompletedNCT03954054

Therapeutic Education for Harm Reduction in People With Addiction

Official study title

Evaluation of a Therapeutic Education Programme for Harm Reduction in People With Alcohol Use Disorder

This study has finished and is no longer accepting participants.

In France
AddictionObservational studyAges 18+
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Other study type icon
CompletedNCT03437772

Third Generation Cognitive Behavioural Therapy vs Treatment-as-usual for ADHD

Official study title

Third Generation Cognitive Behavioural Therapy Versus Treatment-as-usual for Attention Deficit and Hyperactivity Disorder: a Randomized, 2-parallel-group, Evaluator Blinded, Superiority Trial

This study has finished and is no longer accepting participants.

In France
ADHDObservational studyAges 7–15
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Drug study icon
TerminatedNCT03351244

This Study Tests Whether BI 409306 Prevents people with Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months

Official study title

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Orally Administered BI 409306 During a 28-week Treatment Period as Adjunctive Therapy to Antipsychotic Treatment for the Prevention of Relapse in Patients With Schizophrenia.

This study ended early.

In France
SchizophreniaMedication studyAges 18–55
Countries
France, United States, Canada, + 4 others
Sponsor
Boehringer Ingelheim

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.